International Pharmaceutical Manufacturing site new registration

Licensing of international manufacturing sites with the National Health Regulatory Authority (NHRA) is a mandatory requirement that must be fulfilled prior to the submission of any application for new product registration or a variation application involving a relevant site transfer. This ensures that all manufacturing facilities involved in the production of pharmaceutical products meet the regulatory standards set by the NHRA, thereby upholding product quality, safety, and compliance with national health regulations. the applications are submitted on Adweya Portal.